- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02082093
Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure (eNephro)
The main objective of this study is to demonstrate the efficiency ( cost-effectiveness ) of a telemedicine system : eNephro Application , compared with traditional care in the management of chronic renal failure in different populations :
- population 1 : Patients with CKD stage 3B- 4 , the combined endpoint achievement of target blood pressure and proteinuria .
- population 2 : Patients with ESRD treated by ambulatory dialysis , the cumulative duration of hospitalization in short-stay
- population 3 : Patients with ESRD treated with Renal Transplantation , the cumulative duration of unplanned short stay
Two statistical analysis will be done :
- a main analysis for the one year initial follow-up for each patient
- a secondary analysis for the one year initial follow-up estended by one year (proposed to each patient at the end of the initial follow-up), that is a 2 years period.
The intervention tested in this study is a telemedicine system which is a collaborative and expert system, consisting of:
- A dynamic shared medical record for the collection of administrative , medical, biological and clinical data for each patient. All health professionals can access the folder and fill in the support. It is the same for patients treated at home.
- A secure messaging for communication between health professionals and between patients and health professionals
- Expert systems analyzing data from each patient
- A management tool of therapeutic education
Each patient and whatever the group will perform as part of its monitoring of the CKD assessments at baseline , 6 months, 12 months, 18 months (Populations 1 and 2) and end of study (24 months). These evaluations are about compliance, quality of life, anxiety - depression state. To enhance costs the point of view retained will be health insurance's point of view. Among the various costs, only direct costs are considered: disease management, hospitalizations, consultations in hospitals and private practice, prescribed medical transportation , home visits by health professionals, additional assessments related to the evaluated intervention. A probabilistic matching with the data bases of the National Information System of the Social Insurance will be performed. In addition, the acceptability of the system of telemedicine by patients in the intervention and health professionals will be also evaluated.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Three populations are recruited with the following inclusion criteria:
- age ≥ 18 years;
- ability to use a tablet device (alone or with assistance);
- population 1: stabilised stage 3B or stage 4 CKD with nephrology management of less than 3 years;
- population 2: stage 5D CKD treated by homecare peritoneal dialysis (PD) or out centre haemodialysis (HD);
- population 3: stage 5T CKD treated by renal transplantation for 3 to 12 months.
Non-inclusion criteria are:
- dialysis after renal transplantation failure;
- organ transplantation other than kidney;
- life expectancy < 1 year.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France
- CHU Bordeaux
-
Bordeaux, France
- Aurad Aquitaine
-
Boulogne sur Mer, France
- CH Boulogne sur Mer
-
Brest, France
- TELECOM Bretagne
-
Dunkerque, France
- Ch Dunkerque
-
Lille, France
- CHU Lille
-
Nancy, France
- Chu Nancy
-
Nancy, France
- ALTIR
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with CKD Stage 3B 4 ESRD patients receiving ambulatory dialysis , Patients treated with Renal Transplantation
- In CKD patients stage 3B 4: nephrology care ≤ 3 years, for transplant patients: Renal Transplantation ≥ 3 months but ≤ 12 months
- Patients can use an IT tool or having in their entourage one who knows how to use
Exclusion Criteria:
- Acute Renal Failure at the time of inclusion
- Patient in transplant failure
- Patient with another organ transplant
- Patient whose life is at stake in the short term (Life expectancy <1 year)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Traditional Care
|
|
Experimental: eNephro Application
Telemedicine system which is a collaborative and expert system, consisting of: A dynamic shared medical record for the collection of administrative , medical, biological and clinical data for each patient. All health professionals can access the folder and fill in the support. It is the same for patients treated at home. A secure messaging for communication between health professionals and between patients and health professionals Expert systems analyzing data from each patient A management tool of therapeutic education These patients have a chronic renal failure moderate to end up being treated by ambulatory dialysis or kidney transplantation. The patients of each population will be randomly assigned in group 1 ie traditional care or in group 2 ie traditional care added by telemedicine system |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Combined endpoint achievement of target blood pressure and proteinuria
Time Frame: one year
|
population 1 : Patients with CKD stage 3B- 4 , the combined endpoint achievement of target blood pressure and proteinuria
|
one year
|
Cumulative duration of hospitalization in short-stay for 1 year
Time Frame: one year
|
population 2 : Patients with ESRD treated by ambulatory dialysis , the cumulative duration of hospitalization in short-stay for 1 year
|
one year
|
Cumulative duration of unplanned short stay for 1 year
Time Frame: One year
|
population 3 : Patients with ESRD treated with Renal Transplantation , the cumulative duration of unplanned short stay for 1 year
|
One year
|
Survival
Time Frame: One Year
|
Population 2 : Survival without events event = hospitalization whatever the duration and/or return to in-center dialysis
|
One Year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compliance
Time Frame: Base Line, 6 months, One Year
|
Girerd's auto questionnaire to assess compliance
|
Base Line, 6 months, One Year
|
Quality of Life of patients
Time Frame: Base Line, One Year
|
Populations 1 and 2 : KDQoL questionnaire to assess quality of life Population 3 : Re TRANSQoL questionnaire
|
Base Line, One Year
|
Anxiety-Depression State
Time Frame: Base Line, One Year
|
HAD Questionnaire
|
Base Line, One Year
|
Change in the glomerular filtration rate
Time Frame: Base Line, One Year
|
Population 1 : One Year Change in the GFR estimated by MDRD equation (delta GFR/year)
|
Base Line, One Year
|
Anemia Control
Time Frame: One Year
|
the anemia control is assessed by the achievement of hemoglobin, ferritin and saturation coefficient Transferrin targets
|
One Year
|
Change in the glomerular filtration rate
Time Frame: Base Line, One Year
|
Population 3 : One Year Change in the GFR estimated by MDRD equation (delta GFR/year)
|
Base Line, One Year
|
Consultations and Hospitalizations unplanned
Time Frame: One Year
|
Number of consultations and conventional hospitalizations unplanned in Transplantation center over a year
|
One Year
|
Disease's Costs
Time Frame: One Year
|
To enhance cost, the health insurance's point of a view is retained. Among the various costs, only direct costs are taken into account , there are :
|
One Year
|
Intervention's costs
Time Frame: One Year
|
Costs related to the evaluated intervention : Costs installation, equipment , training and maintenance of the telemedicine system
|
One Year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability
Time Frame: One Year
|
Acceptability questionnaire
|
One Year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michèle Kessler, Pr, CHU Nancy, Nephrology Service
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- eNephro
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingKidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)France
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
University of WashingtonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsRecruitingChronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditionsUnited States
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
Clinical Trials on Telemedicine System
-
Province of Malaga Health DepartmentRoche Diagnostics Spain (Diabetes Care)CompletedType 2 Diabetes | Telemedicine | Primary Care | Self Monitoring Blood GlucoseSpain
-
Chang Hee, LeePurdue University; LG Electronics Inc.CompletedHypertensionKorea, Republic of
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationNot yet recruiting
-
University of RochesterAgency for Healthcare Research and Quality (AHRQ)CompletedTelemedicine | Physical DisordersUnited States
-
Wenwen YinUnknown
-
NHS Greater Glasgow and ClydeJean Brown Bequest Fund, Glasgow, UKNot yet recruitingTelemedicine | Surgery, PlasticUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationCompletedTelemedicine | Reconstructive Surgery | 3 DimensionalUnited Kingdom
-
Universidad de AlmeriaCompleted
-
University of TromsoCompletedCardiovascular DiseaseNorway
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Glasgow Royal InfirmaryNot yet recruiting